'Esbl' diaporamas de présentation

EXTENDED SPECTRUM B-LACTAMASES (esbl) basis, detection and reporting

EXTENDED SPECTRUM B-LACTAMASES (esbl) basis, detection and reporting. Dr.T.V.Rao MD. V. cholera. C. jejuni. Helicobacter pylori. Acinetobacter spp. Gram Negative Bacilli. Many other ( H. influenza , etc..). Stenotrophomonas maltophilia. Pseudomonas aeruginosa. Enterobacteriaceae.

1.2k views • 69 slides

620 views • 52 slides

Clinical Interpretation of MICs in the Era of Multidrug Bacterial Resistance

Clinical Interpretation of MICs in the Era of Multidrug Bacterial Resistance. Wael E Shams, M.D. Division of Infectious Diseases Department of Internal Medicine James H Quillen College of Medicine East Tennessee State University. Conflict of Interest & Disclosure.

638 views • 50 slides

Clinical Interpretation of MICs in the Era of Multidrug Bacterial Resistance

Clinical Interpretation of MICs in the Era of Multidrug Bacterial Resistance. Wael E Shams, M.D. Division of Infectious Diseases Department of Internal Medicine James H Quillen College of Medicine East Tennessee State University. Conflict of Interest & Disclosure.

597 views • 50 slides

Gram Negatives : Clinical Management of the Multi-drug Resistant infections

617 views • 46 slides

Detection of b -lactamase- mediated resistance

Detection of b -lactamase- mediated resistance. David Livermore Health Protection Agency, Colindale, London. Main b -lactamase threats. Extended-spectrum b -lactamases TEM, SHV & CTX-M types AmpC Derepressed chromosomal e.g Enterobacter Plasmid-mediated in E. coli & Klebsiella

683 views • 41 slides

Emerging Antimicrobial Resistance in Texas

Emerging Antimicrobial Resistance in Texas. The new ESBLs. Most Important Emerging Resistance. MRSA in the community Resistance to alternative drugs for MRSA, including vancomycin Re-emergence of DRSP ESBL in various gram-negative species Carbapenemases in various GNs

332 views • 32 slides

Abstract

76 views • 1 slides